INTRODUCTION
Prior to the identification, cloning, and characterization of their coat proteins, the functions of caveolae− flask-shaped invaginations of the plasma membrane (1) also termed plasmalemmal vescicles (2) − remained obscure (3). Several investigations had implicated caveolae in a specialized form of endocytosis termed potocytosis, the large-scale uptake of fluids and small molecules (reviewed in ref. 4). However, application of molecular biological techniques to the study of caveolae dramatically widened our knowledge of their roles in cellular physiology. The simultaneous identification of a 22 kDa phosphoprotein first detected in Rous Sarcoma Virustransformed fibroblasts (5) as caveolin, the principal caveolae membrane coat protein (now termed caveolin-1) (6), and as VIP21 (vesicular integral membrane protein of 21 kDa), a component of detergent resistant trans-Golgi derived vesicles (7), added signal transduction and intracellular transport to the possible functions of caveolae. Both of these potential roles were realized (see below). Notably, two other mammalian caveolin proteins (caveolin-2 and caveolin-3) have been cloned, and have unique distributions and functions (Table 1) .
The essential role of caveolin-1 in caveolae organelle biogenesis has been documented in cell lines that do not express any known caveolins endogenously. Heterologous expression of caveolin-1 is sufficient to form caveolae in lymphocytes (8), insect cells (9, 10), and transformed fibroblasts (11), i.e., cells that otherwise lack caveolin-1 expression and morphological caveolae. Caveolin-1 expression is sufficient to induce this architectural change in the plasma membrane because caveolin-1 actively contributes to the organization of cholesterol and saturated lipids within these vesicular invaginations of the plasma membrane (12-15). The high concentration of cholesterol in caveolae and the tight association of cholesterol with caveolins (13, 16) reflects another function of caveolae and caveolins. They are components of the cell's transport machinery, contributing to the influx and efflux of cellular cholesterol (17-24).
A third function for caveolin proteins was also suggested by the early descriptive reports of caveolins as transformation-dependent substrates of v-Src (5, 25). Here, we review the discovery and study of caveolin proteins, emphasizing results that address how these proteins give rise to morphological caveolae, how they contribute to cholesterol traffic, and how they regulate signaling protein function.
CAVEOLIN IDENTIFICATION
Using anti-phosphotyrosine IgG (PY20), Glenney identified several proteins selectivley phosphorylated in vSrc-transformed cells. One of these phosphoproteins was a 22 kDa (p22) molecule that was resistant to extraction with Triton X-100, migrated as a high mass complex through glycerol gradients, and resided at the plasma membrane (5, 25).
Immunoelectron microscopy revealed that the anti-p22 antibody binds an antigen that is found in the coat of caveolae membranes. Since p22 was the first marker of caveolae membranes, it was termed caveolin (caveolin-1). Unlike clathrin lattices, the caveolar coats resist destruction (as assessed by scanning electron microscopy with antip22 antibodies) when exposed to high concentrations of salt. Surprisingly, caveolae are exquisitely sensitive to nystatin, a cholesterol-binding drug.
Caveolinimmunoreactivity and the characteristic striated morphology of caveolae are lost from the plasma membrane upon nystatin treatment (6).
Shortly after caveolin-1's identification came the cloning of VIP21 (7). This protein is a component of transGolgi derived transport vesicles. Immunogold microscopy revealed that it resides in non-coated vesicles on the plasma membrane as well as in the trans-Golgi. VIP21 resists extraction with alkaline sodium carbonate (an agent that strips membranes of peripherally associated proteins) and non-ionic detergents (7). Cloning of the caveolin-1 cDNA revealed that it is identical to VIP21 (32, 33) .
CAVEOLIN TOPOLOGY AND STRUCTURE
The primary sequence of caveolin-1 contains a central hydrophobic domain (residues 102-134) that is believed to anchor the protein to membranes (33) (Figure  1 ). Given its tight association with membranes and its unusual primary structure (i.e. a single hydrophobic domain, no signal sequence), a major thrust in the study of caveolin-1 has been the determination of its membrane topology. Several studies have convincingly established that caveolin-1 is split into two large cytoplasmic domains by the central hyrophobic membrane anchor (Figure 1) . Evidence for this model includes (i) the failure of antibodies directed against either the N-or C-terminus of caveolin-1 to detect the molecule in unpermeablized cells (34, 35) ; (ii) the lack of sugar modification when artificial glycosylation sites are placed at either the extreme N-or Ctermini (36); (iii) the inaccessibility of caveolin-1 in MDCK cells to surface biotinylation (37) ; and (iv) the presence of cytoplasmic post-translational modifications (phosphorylation and palmitoylation) at the N-and Ctermini (35, 38) .
The unusual membrane topology remains an important area of investigation, and work performed over the last two years by our group (39, 40) and by others (41, 42) has revealed that caveolins bind to biological membranes through two unconventional Membrane Attachment Domains (MADs). More specifically, the portions of the molecule flanking the central hydrophobic domain can each bind to membranes with high affinity. Furthermore, these two MADs target to different cellular compartments with the N-terminal MAD (N-MAD) targeting to caveolae membranes and the C-MAD targeting to the trans-Golgi. Further work is required to clarify the biological consequences of these multiple targeting sequences, but they provide mechanistic insights into how "monotopic" proteins like caveolins associate with biological membranes.
Caveolin-1 and -3 can each form homotypic high molecular mass oligomers containing ~ 14-16 individual molecules (36, 37, 43) .
In the ER (44), homooligomerization is mediated by a forty amino-acyl residue domain (residues 61-101 in caveolin-1) within the N-terminal portion of the molecule (37) . In the Golgi, adjacent homooligomers undergo a second stage of oligomerization; they interact with one another through contacts between the Cterminal domains of caveolin, in a side-by-side packing scheme ( Figure 1) (40, 45) . These oligomer/oligomer interactions then produce an interlocking network of caveolin molecules that gives rise to the striated caveolar coat seen by scanning electron microscopy.
CAVEOLAE, CAVEOLIN, AND SUBCELLULAR CHOLESTEROL TRAFFIC
After establishing that caveolae are sensitive to cholesterol depletion (and oxidation), Anderson and colleagues assessed the effects of nystatin and cholesterol oxidase treatment on caveolin-1 localization. They found that depletion of cellular cholesterol with either of these agents causes a retreat of caveolin-1 from caveolae to internal membrane compartments (46, 47). Restoring cellular cholesterol causes caveolin-1 to return to plasma membrane caveolae. Independent studies performed with bacterially expressed caveolin-1 confirmed an essential role for cholesterol in caveolin-1 attachment to membranes. Caveolin-1 incorporates into reconstituted lipid vesicles only when the vesicles contain high cholesterol concentrations (13, 14). Furthermore, caveolin-1 is tightly associated with cholesterol in vitro (13).
Given the exquisite sensitivity of caveolae morphology and caveolin-1 localization to cholesterol, it comes as no surprise that caveolae and caveolin-1 are important components of the cell's cholesterol transport machinery. In a series of pulse-chase experiments, Fielding and Fielding established that caveolae mediate the efflux of cellular cholesterol. Both LDL-derived cholesterol (which is internalized by clathrin-coated pits) and newly synthesized cholesterol reach the plasma membrane through caveolae (17, 18). Figure 2A summarizes the known modes of cholesterol uptake and delivery to lipoprotein particles.
As expected, caveolin-1 is an active component of the cholesterol transport machinery (19), and its expression in cell lines lacking endogenous caveolin-1 markedly enhances the rate of delivery of newly synthesized cholesterol to caveolae. Kinetic, cellular fractionation, and immunoprecipitation studies by Smart and his colleagues have uncovered a novel mode of caveolin-1 trafficking from the endoplasmic reticulum (the site of cholesterol synthesis) to caveolae membranes (Figure 2 ). More specifically, caveolin-1 travels between these two membrane compartments as a cytosolic complex containing chaperone proteins and cholesterol (20). Although caveolin-1 palmitoylation is not required for targeting to caveolae (35) , the ability of cytosolic caveolin-1 to bind and transport cholesterol requires palmitoylation (24).
The physiological significance of caveolae in cholesterol homeostasis is supported by the observation Figure 2 . Cholesterol transport and caveolin-1 traffic. A) LDL particles are bound to the LDL receptor and internalized via clathrin coated pits. The complex dissociates as the coated vesicle's pH drops. The proteins in the LDL particle are then degraded by lysosomal enzymes, while the receptor recycles to the plasma membrane. HDL particles are not internalized. Rather, bidirectional flow of cholesterol to and from these lipoprotein particles occurs in caveolae, and is mediated by the HDL receptor, SR-BI (red). B)The various routes caveolin-1 takes in its intracellular traffic are shown using different colors. The biosynthetic pathway (green) involves co-translational insertion of the protein into the endoplasmic reticulum (ER) membrane, traffic through the ER, the Golgi complex, trans-Golgi network (TGN), and ultimate residence in caveolae vesicles (7, 13, 44). The yellow arrow and vesicles indicate the cycling of caveolin-1 between the trans-Golgi and caveolae membranes (34) . The blue arrow indicates the path of cytosolic caveolin-1 in complex with chaperone proteins in delivering newly synthesized cholesterol from the ER to caveolae (19, 20, 24 ). The red arrow shows the retreat of caveolin-1 from caveolae membranes to the lumen of the ER in cells depleted of plasma membrane cholesterol (46, 47). For simplicity, the ER is shown as a perinuclear ring. Ternary complex containing caveolin-1, Src, and GRB7. Upon growth factor stimulation, the non-receptor tyrosine kinase Src is activated and catalyzes the phosphorylation of caveolin-1 on Tyr 14 . Phosphorylated caveolin-1 then binds the adapter protein GRB7, transmitting the signal through a novel signaling cascade. Src has three domains: a kinase domain (KD, also called Scr homology 1, SH1), and two tandem protein-protein interaction domains, SH-2 and SH-3. Also, Src bears a myristoyl group on the N-terminal glycine residue.
that the HDL receptor SR-BI (type I, class B scavenger receptor) is a resident caveolar protein (48) . Furthermore, the bidirectional flow of cholesterol between HDL particles and the cell occurs in caveolae (21, 22). However, genetic ablation studies will be required to establish the role of caveolin-1 in cholesterol traffic in whole animals. More specifically, the effects of caveolin-1 deficiency on reverse cholesterol transport (i.e. periphery to liver), and on the development of dyslipidemia (and its sequelae) must be examined in mice lacking the caveolin-1 gene. Other unresolved areas include the relationship between caveolin-1 and sterol carrier proteins (see ref. 49 and citations therein).
The oxidized low-density lipoprotein receptor CD36, which mediates the conversion of macrophages to foam cells in the intima of blood vessels undergoing atherosclerosis, also resides in caveolae (50) . The role of this subcellular localization and of caveolae and caveolins in this disease can also be examined in CAV1 null mice. Crosses with animals with a propensity to develop atherosclerosis (e.g. APOE null) or hypertension (e.g. ENOS null) will also be informative. Other areas of interest include the role of caveolins in the uptake of dietary cholesterol by enterocytes (51).
CAVEOLIN-1 AND SIGNAL TRANSDUCTION

The Caveolae Signaling Hypothesis and the Caveolin Scaffolding Domain
The unique lipid and protein composition of caveolae membranes renders caveolae resistant to non-ionic detergent membranes (52) . Development of purification methods that exploit this detergent-insolubility of caveolae membranes led to the identification of caveolae-associated proteins (27). Many caveolae resident proteins are signaling molecules (53) . This discovery prompted us to propose that caveolae are a sub-compartment of the plasma-membrane where signal transduction events occur (50); clustering of signaling proteins in this environment may result in more rapid cross-talk and promote efficiency of signal transmission (50) . The 'Caveolae Signaling Hypothesis' was extended to include a more active role for caveolin-1 after the discovery that caveolin-1 interacts with and regulates the activity of several caveolae-associated signaling proteins (54) (55) (56) . This interaction is direct, and is mediated largely by a 20 amino-acyl residue domain termed the caveolin scaffolding domain (residues 82-101).
Phage display revealed that the caveolin scaffolding domain binds to a motif ( ΦXΦXXXXΦ, ΦXXXXΦXXΦ, and ΦXΦXXXXΦXXΦ, where Φ is a phenylalanine, tyrosine, or tryptophan residue; and X is any aminoacyl residue, ref. 57 With some notable exceptions (reviewed in ref . 68) caveolin-1 inhibits the activity of its interaction partners. In some cases, caveolin-1 binding maintains a signaling protein in an inactive state until a stimulus is presented (e.g. eNOS). For other signaling proteins, caveolin-1 binding serves to terminate signal transmission after activation (e.g. G α). In both cases, caveolin-1 interaction is dynamic and tightly regulated (64, 69) .
Although many proteins interact with caveolins during different parts of their activation cycle, several recent studies reveal that caveolins form ternary complexes with Src family kinases and signaling proteins that lack inherent catalytic activity. For example, caveolin-1 and Fyn associate with the short cytoplasmic tails of beta-1 integrins. Anchorage dependent growth requires the ligation of extracellular ligands to the latter and the concomitant association and activation of caveolin-bound Fyn (reviewed in ref. 70) . Other proteins like the glycosylphosphatidyl inositol-linked (GPI) urokinase receptor u-PAR also regulate integrin function and are part of the integrin/caveolin complex (71) .
The association of GPI anchored proteins with caveolae was first deemed an experimental artifact (72, 73) . However, studies of u-PAR, caveolin-1, Src family kinases and integrins indicate that the compartmentalization of signaling proteins in caveolae is highly dynamic and subject to multiple regulatory inputs. Indeed, other GPI-anchored proteins like the cellular prion protein (PrP) signal through caveolin-1 and Src family kinases upon immunoglobulindependent clustering of PrP in caveolae (74).
Caveolin-1 tyrosine phosphorylation and SH2-domain bearing signaling proteins
In addition to the caveolin scaffolding domain, caveolins contain other protein-protein interaction domains (39, 40, 45, 66, 75, 76) . We recently uncovered a novel interaction between caveolin-1 and the SH2 domain containing adapter molecule GRB7 (Figure 3) . Caveolin-1 binds GRB7 following growth factor-stimulated (and Srccatalyzed) phosphorylation of caveolin-1 tyrosine residue 14. Mutation of this residue to prevent phosphorylation undermines GRB7 association. When co-expressed, Src, Cav-1, and GRB7 dramatically increase anchorageindependent growth and cell migration (77) . Down stream effector molecules remain to be identified, but this series of protein-protein interactions defines the first biological function for caveolin-1 tyrosine phosphorylation.
Caveolin-1 and Cellular Transformation
The majority of studies examining caveolinmediated regulation of signal transduction have been performed in cell culture. However, recent reports indicate that the role of caveolin-1 in regulating signaling is not limited to this setting. For instance, down-regulation of caveolin-1 through RNAinterference in the gonad of Caenorhabditis elegans hermaphrodites results in a phenotype (accelerated meiotic progression and egg-laying) that is identical to that observed when activated Ras and MAP kinase mutants are expressed in this organ (78) .
Notably, a phenocopy of caveolin-downregulation is observed when worms are depleted of cholesterol with methyl-β-cyclodextrin (78) . These results confirm earlier findings obtained in mammalian cell culture: cholesterol depletion or transfection of caveolin-1 anti-sense constructs result in hyperactivation of the Ras/MAP kinase signaling cascade (79, 80) .
The importance of caveolin-1 as an antagonist of mitogenic signaling is underscored by the observation that caveolin-1 is downregulated in cancer cell lines (81) . Indeed, re-expression of caveolin-1 in Ras transformed fibroblasts abrogates anchorage-independent growth (11). Other tumor cell lines cease to proliferate when caveolin-1 is over expressed (82) . Conversely, stable transfection of anti-sense caveolin-1 vectors results in anchoragedependent growth in vitro (i.e. in soft agar), and in vivo (i.e. tumors in nude mice, ref. 80 ).
Other lines of evidence suggest that CAV1 is the tumor suppressor gene residing at chromosome 7q3.1. Namely, CAV1 maps close to the CA-repeat microsatellite marker D7S522, a marker frequently deleted in a variety of human epithelial tumors including breast, prostate, ovarian, and renal cell carcinomas (83) . Also, D7S522 spans the common fragile site, FRAG7, that resides at 7q31.1 (68).
PERSPECTIVE
The cloning of caveolin proteins over the last decade has stimulated research into the functions of caveolae in cell biology. During this period many exciting results have been gathered from test tubes and cell culture dishes. More studies in these familiar settings will be performed in the future. However, we anticipate many exciting new results in whole animals as well. 
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